Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy

被引:44
|
作者
Ray, P [1 ]
Quantin, X [1 ]
Grenier, J [1 ]
Pujol, JL [1 ]
机构
[1] CHU Montpellier, Hop Arnaud de Villeneuve, Serv Malad Resp, F-34295 Montpellier, France
来源
CANCER DETECTION AND PREVENTION | 1998年 / 22卷 / 04期
关键词
chemotherapy; CYFRA; 21-1; cytokeratins; lung cancer; neuron-specific enolase; survival; tissue polypeptide-specific antigen; tumor markers; tumor response;
D O I
10.1046/j.1525-1500.1998.CDOA43.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was (i) to determine predictive factors of a complete response to chemotherapy in small cell lung cancer (SCLC) and predictive factors of an objective response in non-small cell lung cancer (NSCLC) and (ii) to determine whether prognostic factors are different with regard to treatment response and survival. Ninety-nine patients with SCLC and two hundred and two patients with NSCLC received chemotherapy. The following variables were recorded prior to treatment: tumor, node, metastasis status, performance status, body weight loss, blood leukocyte count, serum sodium, serum albumin, lactate dehydrogenase (LDH), alkaline phosphatase, serum NSE, serum TPS, and serum CYFRA 21-1. Tumor response was analyzed at the 10th week. Analysis of survival were done using the landmark method. Hazard ratios of the significant prognostic variables of survival were calculated using the Cox's model. Odds ratios of the significant predicting factors of response were calculated by stepwise logistic regression. In SCLC, the significant determinants of poor survival were: lack of complete response (HR: 2.04), weight loss (HR: 1.76), high serum LDH level (HR: 1.64), and high serum TPS level (HR: 2.47). A high serum TPS level was the only factor among those studied able to predict lack of achievement of complete response (OR: 0.39). In NSCLC, significant determinants of poor survival were: no objective response (HR: 2.28), poor performance status (HR: 2.52), presence of metastases (HR: 1.51), and high serum CYFRA 21-1 level (HR: 1.84). On the other hand, a high serum TPS level (OR: 0.50), the presence of metastases (OR: 0.45), and a leukocyte blood count over 10,000/mu l (OR: 0.43) were independent determinants for a patient not to achieve an objective response. We concluded that the predictive factors of complete response in SCLC remain to be defined. On the other hand, in NSCLC three variables contribute to the prediction of an objective response. Finally, determinants of survival differ from predictive factors of response.
引用
收藏
页码:293 / 304
页数:12
相关论文
共 50 条
  • [1] Biological Prognostic and Predictive Factors in Lung Cancer
    Rossi, Antonio
    Galetta, Domenico
    Gridelli, Cesare
    ONCOLOGY, 2009, 77 : 90 - 96
  • [2] Predictive factors for tumor response to chemotherapy in patients with pancreatic cancer
    Fujishiro, M
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    Watanabe, H
    Tanaka, N
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1744 - 1746
  • [3] Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy
    Tamminga, Menno
    de Wit, Sanne
    Schuuring, Ed
    Timens, Wim
    Terstappen, Leon W. M. M.
    Hiltermann, T. Jeroen N.
    Groen, Harry J. M.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 854 - +
  • [4] PROGNOSTIC FACTORS FOR SURVIVAL IN TERMINAL LUNG-CANCER PATIENTS
    SCHONWETTER, RS
    ROBINSON, BE
    RAMIREZ, G
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1994, 9 (07) : 366 - 371
  • [5] Glioblastoma: Prognostic Factors and Predictive Response to Radio and Chemotherapy Subscribed
    Fiorica, Francesco
    Colella, Maria
    Taibi, Rosaria
    Bonetti, Andrea
    Giuliani, Jacopo
    Perrone, Maria Sole
    Missiroli, Sonia
    Giorgi, Carlotta
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (17) : 2814 - 2825
  • [6] Prognostic factors in lung cancer
    Paesmans, M
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : S76 - S80
  • [7] Predictive factors for response to chemotherapy in colorectal cancer patients
    Vincenzi, B
    La Cesa, A
    Santini, D
    Schiavon, G
    Grilli, C
    Graziano, F
    Tonini, G
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 45 - 60
  • [8] Survival and prognostic factors in small cell lung cancer
    Jian Li
    Chun-Hua Dai
    Ping Chen
    Jian-Nong Wu
    Quan-Lei Bao
    Hao Qiu
    Xiao-Qin Li
    Medical Oncology, 2010, 27 : 73 - 81
  • [9] Survival and prognostic factors in small cell lung cancer
    Li, Jian
    Dai, Chun-Hua
    Chen, Ping
    Wu, Jian-Nong
    Ban, Quan-Lei
    Qiu, Hao
    Li, Xiao-Qin
    MEDICAL ONCOLOGY, 2010, 27 (01) : 73 - 81
  • [10] TUMOR RESPONSE EVALUATION DURING LUNG-CANCER CHEMOTHERAPY
    PUJOL, JL
    PARRAT, E
    RAY, P
    LEHMANN, M
    GAUTIER, V
    MICHEL, FB
    REVUE DE MEDECINE INTERNE, 1995, 16 (10): : 759 - 766